Wednesday, 30. October 2024 Share: YouTube RSS

Eisai stock slumps after Alzheimer’s drug fails to get approval in Europe

Eisai shares fell sharply after its Alzheimer’s drug failed to secure marketing approval in the European Union.

Source: MarketWatch

Continue reading...

Related Articles

×